Polar Asset Management Partners Inc. Bausch Health Companies Inc. Transaction History

Polar Asset Management Partners Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $31,400 - $49,250	-5,000 Reduced 20.0%	20,000 $162,000
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $152,250 - $198,250	-25,000 Reduced 50.0%	25,000 $157,000
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $229,000 - $460,500	50,000 New	50,000 $344,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $423,600 - $1.42 Million	-60,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $1.3 Million - $1.67 Million	60,000 New	60,000 $1.37 Million

275

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.99B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.